{"id":615,"date":"2018-11-11T17:57:48","date_gmt":"2018-11-11T17:57:48","guid":{"rendered":"http:\/\/www.irlab.se\/?page_id=615"},"modified":"2022-02-11T16:53:04","modified_gmt":"2022-02-11T15:53:04","slug":"aktriekapitalets-utveckling","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/","title":{"rendered":"Aktiekapitalets utveckling"},"content":{"rendered":"\n

Aktiekapitalets utveckling<\/h1>\n\n\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
\u00c5r<\/th>H\u00e4ndelse<\/th>Totalt
\naktie-kapital (kr)<\/th>		F\u00f6r-\u00e4ndring (kr)<\/th>Totalt antal aktier<\/th>F\u00f6r-\u00e4ndring aktier<\/th>Emitterat belopp (kr)<\/th>Kvot-v\u00e4rde (kr)<\/th>\n<\/tr>\n<\/thead>\n
2013<\/td>Nybildning<\/td>50 000<\/td>50 000<\/td>100 000<\/td>100 000<\/td>25 000 000<\/td>0,50<\/td>\n<\/tr>\n
2015<\/td>Nyemission<\/td>84 473<\/td>34 473<\/td>168 946<\/td>68 946<\/td>24 106 969<\/td>0,50<\/td>\n<\/tr>\n
2015<\/td>Nyemission<\/td>104 169<\/td>16 696<\/td>208 338<\/td>39 392<\/td>14 772 000<\/td>0,50<\/td>\n<\/tr>\n
2015<\/td>Nyemission<\/td>115 379<\/td>11 210<\/td>230 757<\/td>22 419<\/td>8 047 125<\/td>0,50<\/td>\n<\/tr>\n
2015<\/td>Aktieuppdelning<\/td>115 379<\/td><\/td>2 307 570<\/td>2 076 813<\/td><\/td>0,05<\/td>\n<\/tr>\n
2015<\/td>Apportemission<\/td>181 358<\/td>65 980<\/td>3 627 162<\/td>1 319 592<\/td>54 515 644<\/td>0,05<\/td>\n<\/tr>\n
2016<\/td>Nyemission<\/td>231 358<\/td>50 000<\/td>4 627 162<\/td>1 000 000<\/td>41 350 000<\/td>0,05<\/td>\n<\/tr>\n
2016<\/td>Nyemission<\/td>249 919<\/td>18 561<\/td>4 998 388<\/td>371 226<\/td>15 350 195<\/td>0,05<\/td>\n<\/tr>\n
2016<\/td>Nyemission<\/td>253 497<\/td>3 578<\/td>5 069 939<\/td>71 551<\/td>726 243<\/td>0,05<\/td>\n<\/tr>\n
2016<\/td>Fondemission<\/td>596 994<\/td>253 497<\/td>5 069 939<\/td>0<\/td>0<\/td><\/td>\n<\/tr>\n
2017<\/td>Nyemission<\/td>699 994<\/td>193 000<\/td>6 999 939<\/td>1 930 000<\/td>115 800 000<\/td>0,10<\/td>\n<\/tr>\n
2018<\/td>Nyemission<\/td>809 994<\/td>110 000<\/td>8 099 939<\/td>1 100 000<\/td>138 600 000<\/td>0,10<\/td>\n<\/tr>\n
2019<\/td>Aktiesplit 1:5<\/td>809 994<\/td>0<\/td>40 499 695<\/td>32 399 756\t<\/td>0<\/td>0,02<\/td>\n<\/tr>\n
2019<\/td>Nyemission<\/td>862 194<\/td>52 200<\/td>43 109 695<\/td>2 610 000<\/td>70 470 000<\/td>0,02<\/td>\n<\/tr>\n
2020<\/td>Nyemission<\/td>969 968<\/td>107 774<\/td>48 498 406<\/td>5 388 711<\/td>145 495 197<\/td>0,02<\/td>\n<\/tr>\n
2020<\/td>Nyemission<\/td>1 034 968<\/td>65 000<\/td>51 748 406<\/td>3 250 000<\/td>130 000 000<\/td>0,02<\/td>\n<\/tr>\n
2022<\/td>Apportemission<\/td>1 037 368<\/td>2 400<\/td>51 868 406<\/td>120 000<\/td>0<\/td>0,02<\/td>\n<\/tr>\n
2025<\/td>Nyemission<\/td>1 698 760<\/td>661 392<\/td>84 938 020<\/td>33 069 614<\/td>115 743 649<\/td>0,02<\/td>\n<\/tr>\n
Vid periodens utg\u00e5ng<\/strong><\/td>1 698 760<\/strong><\/td><\/td>84 938 020<\/strong><\/td><\/td>900 377 022<\/strong><\/td>0,02<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n

Emitterat belopp \u00e4r totalt emitterat belopp inkl. \u00f6verkurs men f\u00f6re emissionskostnader.<\/p>\n","protected":false},"excerpt":{"rendered":"

Aktiekapitalets utveckling Emitterat belopp \u00e4r totalt emitterat belopp inkl. \u00f6verkurs men f\u00f6re emissionskostnader.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":582,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-615","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nAktiekapitalets utveckling - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aktiekapitalets utveckling - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Aktiekapitalets utveckling Emitterat belopp \u00e4r totalt emitterat belopp inkl. \u00f6verkurs men f\u00f6re emissionskostnader.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-11T15:53:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/\",\"url\":\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/\",\"name\":\"Aktiekapitalets utveckling - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2018-11-11T17:57:48+00:00\",\"dateModified\":\"2022-02-11T15:53:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investerare\",\"item\":\"https:\/\/irlab.se\/sv\/investerare\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Aktien\",\"item\":\"https:\/\/irlab.se\/sv\/investerare\/aktien\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Aktiekapitalets utveckling\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aktiekapitalets utveckling - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/","og_locale":"sv_SE","og_type":"article","og_title":"Aktiekapitalets utveckling - IRLAB","og_description":"Aktiekapitalets utveckling Emitterat belopp \u00e4r totalt emitterat belopp inkl. \u00f6verkurs men f\u00f6re emissionskostnader.","og_url":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/","og_site_name":"IRLAB","article_modified_time":"2022-02-11T15:53:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/","url":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/","name":"Aktiekapitalets utveckling - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2018-11-11T17:57:48+00:00","dateModified":"2022-02-11T15:53:04+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/investerare\/aktien\/aktriekapitalets-utveckling\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Investerare","item":"https:\/\/irlab.se\/sv\/investerare\/"},{"@type":"ListItem","position":3,"name":"Aktien","item":"https:\/\/irlab.se\/sv\/investerare\/aktien\/"},{"@type":"ListItem","position":4,"name":"Aktiekapitalets utveckling"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=615"}],"version-history":[{"count":9,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/615\/revisions"}],"predecessor-version":[{"id":7577,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/615\/revisions\/7577"}],"up":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/582"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}